Federal prosecutors are on the brink of deciding whether to indict former FBI Director James Comey, a target of President Trump's ongoing campaign against his adversaries. The focus is on Comey's 2020 testimony to Congress regarding the Russia investigation. With the statute of limitations expiring soon, this decision could escalate the tension between Trump and Comey.
President Trump’s recent comments about Ukraine raise eyebrows as he claims a potential victory over Russia, but is this a genuine strategy shift or simply political rhetoric? Analysis reveals complex motives behind his stance.
NASA's latest advancement in deep space optical communications allows data to be sent via laser beams across hundreds of millions of kilometers, paving the way for future Mars missions and high-definition streaming from space!
Jimmy Kimmel's return to ABC ignites a fierce debate over free speech, drawing in Trump, the FCC, and a host of political figures concerned about media regulation and censorship.
In a groundbreaking collaboration, NASA has awarded Katalyst Space Technologies a contract to raise the orbit of the Swift Observatory, showcasing innovative spacecraft servicing technology to extend its mission lifespan.
A seemingly ordinary bird sighting in Texas has led to a remarkable discovery: a hybrid between green jays and blue jays, highlighting the impact of climate change on species ranges. This groundbreaking find raises questions about future wildlife evolution.
As the government shutdown deadline approaches, the White House's OMB warns federal agencies to prepare layoff plans, raising alarms about job security for thousands of workers. Could mass firings be on the table?
A sniper attack on a Dallas ICE facility has resulted in one death and two critical injuries. The suspected shooter was found dead, prompting an FBI investigation into what is being labeled as an act of targeted violence.
The Trump administration's recent approval of leucovorin as an autism treatment has sparked outrage among experts, with many calling for more research and caution in prescribing this unproven drug.
Alibaba Group's focus on artificial intelligence has ignited investor enthusiasm, leading to a 52% surge in its shares this September, making it the top performer on the Hang Seng Tech Index.
